
STRATA Skin Sciences SSKN
$ 1.3
2.36%
Quarterly report 2025-Q3
added 11-14-2025
STRATA Skin Sciences Operating Cash Flow 2011-2026 | SSKN
Annual Operating Cash Flow STRATA Skin Sciences
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -1.11 M | 1.51 M | 2.1 M | 2.23 M | 2.9 M | 4.14 M | 322 K | - | - | - | -19.2 M | -17.5 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 4.14 M | -19.2 M | -2.73 M |
Quarterly Operating Cash Flow STRATA Skin Sciences
| 2025-Q3 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | -804 K | - | - | - | -817 K | - | -1.1 M | -409 K | -353 K | - | 839 K | 387 K | 153 K | - | 1.75 M | 1.2 M | 598 K | - | 1.12 M | 406 K | 336 K | - | 1.8 M | -68 K | 60 K | - | 2.25 M | 1.7 M | 818 K | - | -1.08 M | -1.57 M | - | - | - | - | - | - | - | - | - | - | - | - | -6.09 M | - | -14.2 M | -9.23 M | -5.32 M | - | -13.5 M | -9.55 M | -4.47 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 2.25 M | -14.2 M | -1.9 M |
Operating Cash Flow of other stocks in the Medical devices industry
| Issuer | Operating Cash Flow | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
AxoGen
AXGN
|
4.54 M | $ 31.63 | 2.03 % | $ 1.4 B | ||
|
Acutus Medical
AFIB
|
-63.1 M | - | -26.83 % | $ 2.62 M | ||
|
Boston Scientific Corporation
BSX
|
3.44 B | $ 95.41 | 0.76 % | $ 140 B | ||
|
Abiomed
ABMD
|
275 M | - | - | $ 17.2 B | ||
|
Allied Healthcare Products
AHPI
|
-4.1 M | - | 3.58 % | $ 2.21 M | ||
|
Alphatec Holdings
ATEC
|
-44.7 M | $ 21.25 | 2.36 % | $ 3.04 B | ||
|
Axonics Modulation Technologies
AXNX
|
3.19 M | - | - | $ 3.31 B | ||
|
Apyx Medical Corporation
APYX
|
-5.25 M | $ 3.6 | 2.86 % | $ 125 M | ||
|
Cognyte Software Ltd.
CGNT
|
46.8 M | $ 9.15 | 2.81 % | $ 657 M | ||
|
Bio-Rad Laboratories
BIO
|
455 M | $ 320.95 | 5.1 % | $ 9.06 B | ||
|
Apollo Endosurgery
APEN
|
-31.3 M | - | - | $ 475 M | ||
|
CONMED Corporation
CNMD
|
167 M | $ 42.12 | 3.97 % | $ 1.3 B | ||
|
Conformis
CFMS
|
-50.2 M | - | - | $ 16.4 M | ||
|
BioSig Technologies
BSGM
|
-4.76 M | - | 37.08 % | $ 85.7 M | ||
|
Bruker Corporation
BRKR
|
251 M | $ 50.6 | 5.18 % | $ 7.54 K | ||
|
EDAP TMS S.A.
EDAP
|
-13.6 M | $ 3.48 | 2.35 % | $ 130 M | ||
|
Abbott Laboratories
ABT
|
8.56 B | $ 126.37 | 1.76 % | $ 220 B | ||
|
Cardiovascular Systems
CSII
|
-24.3 M | - | 0.15 % | $ 844 M | ||
|
Cutera
CUTR
|
-138 M | - | -10.19 % | $ 1.99 M | ||
|
Eargo
EAR
|
-117 M | - | - | $ 10.2 M | ||
|
Electromed
ELMD
|
11.4 M | $ 28.03 | 2.34 % | $ 237 M | ||
|
Second Sight Medical Products
EYES
|
-20.8 M | - | -0.97 % | $ 54.4 M | ||
|
Neovasc
NVCN
|
-27.1 M | - | - | $ 111 M | ||
|
Dynatronics Corporation
DYNT
|
301 K | - | 14.99 % | $ 929 K | ||
|
InMode Ltd.
INMD
|
133 M | $ 15.27 | 3.18 % | $ 1.21 B | ||
|
IRadimed Corporation
IRMD
|
25.6 M | $ 98.11 | 2.73 % | $ 1.24 B | ||
|
Align Technology
ALGN
|
738 M | $ 160.18 | 2.66 % | $ 12 B | ||
|
OrthoPediatrics Corp.
KIDS
|
-27 M | $ 18.13 | 3.22 % | $ 418 M | ||
|
Accuray Incorporated
ARAY
|
2.86 M | $ 0.89 | 4.38 % | $ 91.5 M | ||
|
Avinger
AVGR
|
-14.4 M | - | -20.74 % | $ 369 K | ||
|
ClearPoint Neuro
CLPT
|
-8.95 M | $ 14.34 | 2.21 % | $ 388 M | ||
|
FONAR Corporation
FONR
|
15.3 M | $ 18.52 | 0.03 % | $ 121 M | ||
|
LivaNova PLC
LIVN
|
183 M | $ 63.29 | 4.37 % | $ 3.43 B | ||
|
LENSAR
LNSR
|
-2.28 M | $ 11.32 | -2.5 % | $ 130 M | ||
|
GBS
GBS
|
-9.68 M | - | -0.57 % | $ 7.12 M | ||
|
IRIDEX Corporation
IRIX
|
-6.74 M | $ 1.21 | 3.42 % | $ 19.5 M | ||
|
Globus Medical
GMED
|
521 M | $ 90.81 | 4.02 % | $ 12.3 B | ||
|
Integra LifeSciences Holdings Corporation
IART
|
129 M | $ 12.56 | 4.58 % | $ 967 M | ||
|
Aziyo Biologics
AZYO
|
-21.8 M | - | 1.37 % | $ 20.5 M | ||
|
Establishment Labs Holdings
ESTA
|
-58.5 M | $ 65.25 | -5.21 % | $ 1.84 B |